(Q59200582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Immunopathogenesis of hepatitis C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

A J Freeman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Marinos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R A Ffrench

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

515-536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11903612%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of hepatitis C

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus antibodies among risk groups in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The long-term course of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Are booster immunisations needed for lifelong hepatitis B immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Epidemiology of hepatitis C virus infection among injecting drug users in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C Virus Not Found in Fulminant Non-A, Non-B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C: the clinical spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Antibody to hepatitis C virus in post-transfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis-C-virus-related chronic liver disease of sporadic type: clinical, serological and histological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C in Patients Undergoing Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Genetic organization and diversity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The molecular virology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The Particle Size Of Hepatitis C Virus Estimated By Filtration Through Microporous Regenerated Cellulose Fibre

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus: detection of intracellular virus particles by electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Association of hepatitis C virus in human sera with beta-lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cell fusion activity of hepatitis C virus envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Histopathology and detection of hepatitis C virus in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of hepatitis C virus genome in formalin-fixed paraffin-embedded liver tissue by in situ reverse transcription polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of widespread hepatocyte infection in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of hepatitis C virus (HCV) RNA sequences in liver tissue by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Fluorescent "in situ" hybridization of hepatitis C virus RNA in peripheral blood mononuclear cells from patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Rapid evolution of RNA genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Nucleotide sequence and mutation rate of the H strain of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus genotypes and quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Large-scale analysis of hepatitis C virus serological typing assay: effectiveness and limits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Lack of association between type of hepatitis C virus, serum load and severity of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Immunity in hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The role of CD4 and CD8 T cells in viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

HLA association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Pathogenesis of dengue: challenges to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Vaccination of chimpanzees against infection by the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Establishment of a cell line constitutively expressing E2 glycoprotein of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Viral escape and the failure of cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Long-lasting memory T cell responses following self-limited acute hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Vertical Transmission of Hepatitis B Antigen in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

To kill or to cure: options in host defense against viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Virus 'quasispecies': making a mountain out of a molehill?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The quasispecies of hepatitis C virus and the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Immunopathology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Cytokines in viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

NKT cells: facts, functions and fallacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

The liver as a site of T-cell apoptosis: graveyard, or killing field?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Mechanisms of peripheral T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Virus escape from CTL recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus-associated fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Histological Damage in Chronic Hepatitis C Is Not Related to the Extent of Infection in the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C virus core and E2 protein expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01036.X